Magnetic traction assistance for endoscopic treatment of early gastrointestinal cancers
Magnetic Anchor Guided - Endoscopic Submucosal Dissection (MAG-ESD) for Gastric and Colorectal Superficial Lesions - a Pilot Study
This study is testing whether using magnetic traction can make it easier and quicker for doctors to perform endoscopic surgery on early stomach and colon cancers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06962293 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of magnetic traction to assist in endoscopic submucosal dissection (ESD) for early gastric and colorectal cancers. ESD is a complex procedure that requires effective tissue traction to improve visibility and facilitate the dissection process. The magnetic retractor allows for dynamic manipulation of the tissue, potentially simplifying the procedure compared to traditional static traction methods. By enhancing the dissection technique, this approach aims to improve patient outcomes and reduce procedure time.
Who should consider this trial
Good fit: Ideal candidates include patients with superficial gastric or colorectal lesions scheduled for ESD.
Not a fit: Patients with contraindications such as cardiac pacemakers or metallic implants will not benefit from this study.
Why it matters
Potential benefit: If successful, this method could lead to more efficient and safer endoscopic treatments for early gastrointestinal cancers.
How similar studies have performed: While various traction methods have been explored, the use of magnetic traction in this context is a novel approach that has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with superficial gastric or colorectal lesions, scheduled for endoscopic submucosal dissection (ESD). Exclusion Criteria: 1. Patient who refused to participate 2. Other cases deemed by the examining physician as unsuitable for safe treatment The robotic magnetic countertraction system consist of a strong permanent magnet which always have a strong magnetic field in its surrounding. Therefore, we follow the MRI precautions for the strict safety measurement: 3. Patient who had a cardiac pacemaker. 4. Patient who had any metallic implant or device, such as drug pump, stent, etc. 5. Patient who has or had any metal fragments in eye or any other part of body, or had ever worked with metal.
Where this trial is running
Hong Kong
- Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Study coordinator: Hon Chi Yip, MBChB, FRCSEd (General)
- Email: hcyip@surgery.cuhk.edu.hk
- Phone: +85235052956
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.